GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Relief Therapeutics Holding SA (CHIX:RLFz) » Definitions » Accumulated other comprehensive income (loss)

Relief Therapeutics Holding (CHIX:RLFZ) Accumulated other comprehensive income (loss) : CHF270.80 Mil (As of Jun. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Relief Therapeutics Holding Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Relief Therapeutics Holding's Accumulated other comprehensive income (loss) for the quarter that ended in Jun. 2024 was CHF270.80 Mil.

Relief Therapeutics Holding's quarterly Accumulated other comprehensive income (loss) declined from Jun. 2023 (CHF221.59 Mil) to Dec. 2023 (CHF0.78 Mil) but then increased from Dec. 2023 (CHF0.78 Mil) to Jun. 2024 (CHF270.80 Mil).

Relief Therapeutics Holding's annual Accumulated other comprehensive income (loss) increased from Dec. 2021 (CHF0.26 Mil) to Dec. 2022 (CHF0.72 Mil) and increased from Dec. 2022 (CHF0.72 Mil) to Dec. 2023 (CHF0.78 Mil).


Relief Therapeutics Holding Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Relief Therapeutics Holding's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Relief Therapeutics Holding Accumulated other comprehensive income (loss) Chart

Relief Therapeutics Holding Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 - 0.26 0.72 0.78

Relief Therapeutics Holding Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 215.75 0.72 221.59 0.78 270.80

Relief Therapeutics Holding Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.


Relief Therapeutics Holding Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Relief Therapeutics Holding's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Relief Therapeutics Holding Business Description

Industry
Traded in Other Exchanges
Address
Avenue de Secheron 15, Geneva, CHE, 1202
Relief Therapeutics Holding SA is engaged in the research, development, and commercialization of biopharmaceutical products. It mainly develops drugs of natural human origin. It has a focus on commercial products and the development program pipeline is focused on three main areas: rare genetic, metabolic disorders, rare connective tissue disorders, and rare lung diseases. Its pipeline includes various drug candidates in their different stages of development such as RLF-TD011, and RLF-100, among others. It also has commercial legacy products like Cambia, Setofilm, Voltadol, and Voltfast among others. Geographically the company generates a majority of its revenue from Europe (excluding Switzerland) and the rest from North America, Switzerland, and the rest of the world.

Relief Therapeutics Holding Headlines

No Headlines